Transcriptional activation of the Axl and PDGFR-α by c-Met through a ras- and Src-independent mechanism in human bladder cancer

Table 2 Correlation of c-Met, Axl, and PDGFR-α protein expression with clinicopathologic parameters of patients with locally advanced and metastatic bladder cancers

Expression pattern	Grade	T status*	Multiple	Node (+)	Survival
c-Met	0.561	0.904	0.727	0.321	0.009^†
Axl	0.409	0.105	0.795	0.300	0.789
PDGFR-α	0.344	0.470	0.718	0.049^†	0.027^†
c-Met & Axl	0.140	0.070	0.277	0.061	0.031^†
c-Met & PDGFR-α	0.184	0.686	0.957	0.802	0.011^†
Axl & PDGFR-α	0.439	0.585	0.762	0.369	0.049^†
c-Met & Axl & PDGFR-α	0.595	0.377	0.346	0.281	0.008^†

*Statistical analysis was performed between stage pT2 (21), pT3 (27) and stage pT4 (17), according to TNM (2002) classification criteria.
^† p value less than 0.05.

ISSN: 1471-2407